R.M. Hagan

1.4k total citations
36 papers, 1.1k citations indexed

About

R.M. Hagan is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, R.M. Hagan has authored 36 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Cellular and Molecular Neuroscience, 20 papers in Molecular Biology and 8 papers in Psychiatry and Mental health. Recurrent topics in R.M. Hagan's work include Neuropeptides and Animal Physiology (21 papers), Receptor Mechanisms and Signaling (17 papers) and Pharmacological Receptor Mechanisms and Effects (7 papers). R.M. Hagan is often cited by papers focused on Neuropeptides and Animal Physiology (21 papers), Receptor Mechanisms and Signaling (17 papers) and Pharmacological Receptor Mechanisms and Effects (7 papers). R.M. Hagan collaborates with scholars based in United Kingdom, Netherlands and Germany. R.M. Hagan's co-authors include I.J.M. Beresford, S.J. Ireland, Christopher Jordan, P.J. Birch, P. Ward, M.B. Tyers, Jeffrey Brown, Brian J. Jones, Gavin J. Kilpatrick and Sharon C. Stratton and has published in prestigious journals such as Neuroscience, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

R.M. Hagan

36 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R.M. Hagan United Kingdom	18	916	757	255	142	102	36	1.1k
C H Li United States	13	1.0k 1.1×	904 1.2×	426 1.7×	107 0.8×	44 0.4×	22	1.4k
P J Vaysse United States	9	774 0.8×	629 0.8×	123 0.5×	65 0.5×	72 0.7×	13	1.1k
Jean‐Pierre Dausse France	20	464 0.5×	661 0.9×	179 0.7×	79 0.6×	53 0.5×	32	1.0k
François P. Monnet France	23	1.2k 1.3×	1.4k 1.9×	121 0.5×	100 0.7×	106 1.0×	42	2.0k
Christiane Gueudet France	17	898 1.0×	813 1.1×	126 0.5×	116 0.8×	65 0.6×	23	1.1k
P.F.M. Janssen Belgium	13	736 0.8×	578 0.8×	129 0.5×	62 0.4×	146 1.4×	20	1.1k
V.R. Olgiati Italy	14	472 0.5×	276 0.4×	237 0.9×	80 0.6×	24 0.2×	29	841
Marie‐Claude Burgevin France	14	492 0.5×	464 0.6×	105 0.4×	34 0.2×	40 0.4×	24	750
SM Paul United States	9	763 0.8×	1.0k 1.4×	103 0.4×	67 0.5×	40 0.4×	10	1.4k
Elizabeth Bolan United States	19	1.6k 1.7×	1.3k 1.7×	592 2.3×	45 0.3×	63 0.6×	21	1.8k

Countries citing papers authored by R.M. Hagan

Since Specialization

Citations

This map shows the geographic impact of R.M. Hagan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.M. Hagan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.M. Hagan more than expected).

Fields of papers citing papers by R.M. Hagan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.M. Hagan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.M. Hagan. The network helps show where R.M. Hagan may publish in the future.

Co-authorship network of co-authors of R.M. Hagan

This figure shows the co-authorship network connecting the top 25 collaborators of R.M. Hagan. A scholar is included among the top collaborators of R.M. Hagan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.M. Hagan. R.M. Hagan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Basáñez, María‐Gloria, et al.. (2023). Persistence of onchocerciasis and associated dermatologic and ophthalmic pathologies after 27 years of ivermectin mass drug administration in the middle belt of Ghana. Tropical Medicine & International Health. 28(11). 844–854. 3 indexed citations

Beresford, I.J.M., Colette Browning, Sarah J. Starkey, et al.. (1998). GR196429: A Nonindolic Agonist at High-Affinity Melatonin Receptors. Journal of Pharmacology and Experimental Therapeutics. 285(3). 1239–1245. 31 indexed citations

Drijfhout, W. J., et al.. (1997). A microdialysis study on pineal melatonin rhythms in rats after an 8h phase advance: new characteristics of the underlying pacemaker. Neuroscience. 80(1). 233–239. 11 indexed citations

Beattie, David T., Helen E. Connor, & R.M. Hagan. (1995). Recent developments in tachykinin NK₁receptor antagonists: prospects for the treatment of migraine headache. Canadian Journal of Physiology and Pharmacology. 73(7). 871–877. 21 indexed citations

Beattie, David T., I.J.M. Beresford, Helen E. Connor, et al.. (1995). The pharmacology of GR203040, a novel, potent and selective non‐peptide tachykinin NK₁ receptor antagonist. British Journal of Pharmacology. 116(8). 3149–3157. 56 indexed citations

Stratton, Sharon C., et al.. (1995). The anxiolytic-like activity of GR159897, a non-peptide NK2 receptor antagonist, in rodent and primate models of anxiety. Psychopharmacology. 121(2). 186–191. 60 indexed citations

Stables, Jenny, et al.. (1994). GR138676, a novel peptidic tachykinin antagonist which is potent at NK3 receptors. Neuropeptides. 27(6). 333–341. 17 indexed citations

Stratton, Sharon C., et al.. (1993). Anxiolytic activity of tachykinin NK2 receptor antagonists in the mouse light-dark box. European Journal of Pharmacology. 250(3). R11–R12. 35 indexed citations

Hagan, R.M., Gavin J. Kilpatrick, & M.B. Tyers. (1993). Interactions between 5-HT3 receptors and cerebral dopamine function: implications for the treatment of schizophrenia and psychoactive substance abuse. Psychopharmacology. 112(S1). S68–S75. 45 indexed citations

10.

Palea, Stéfano, et al.. (1993). Further studies on the effects of selective neurokinin agonists upon the activation of micturition reflex in rats. Evidence for a dual NK-1 receptor mediated excitatory and inhibitory activity. Neuropeptides. 24(5). 285–291. 11 indexed citations

11.

Hagan, R.M., I.J.M. Beresford, Jenny Stables, et al.. (1993). Characterisation, CNS distribution and function of NK2 receptors studied using potent NK2 receptor antagonists. Regulatory Peptides. 46(1-2). 9–19. 50 indexed citations

12.

Guo, Jian‐Zhong, Kazuaki Yoshioka, Mitsuhiko Yanagisawa, R.M. Hagan, & Motoyuki Otsuka. (1993). Blockade of cutaneous nerve-evoked responses by GR71251 in the isolated spinal cord preparation of newborn rat. Regulatory Peptides. 46(1-2). 309–310. 6 indexed citations

13.

Beresford, I.J.M., S.J. Ireland, Jenny Stables, & R.M. Hagan. (1992). Ontogeny and characterization of [125I]Bolton Hunter-Eledoisin binding sites in rat spinal cord by quantitative autoradiography. Neuroscience. 46(1). 225–232. 24 indexed citations

14.

Stubbs, Carole M., et al.. (1992). Characterization of human ileum NK2 receptor stably expressed in Chinese hamster ovary cells using NK agonists. Neuropeptides. 22(1). 64–64. 3 indexed citations

15.

Ireland, S.J., et al.. (1991). Receptors mediating tachykinin‐induced contractile responses in guinea‐pig trachea. British Journal of Pharmacology. 103(2). 1463–1469. 58 indexed citations

16.

Hagan, R.M., S.J. Ireland, Christopher Jordan, et al.. (1991). Receptor-selective, peptidase-resistant agonists at neurokinin NK-1 and NK-2 receptors: New tools for investigating neurokinin function. Neuropeptides. 19(2). 127–135. 81 indexed citations

17.

Elliott, Peter J., et al.. (1991). Behavioural and biochemical responses following activation of midbrain dopamine pathways by receptor selective neurokinin agonists. Neuropeptides. 19(2). 119–126. 49 indexed citations

18.

Ward, P., et al.. (1990). Potent and highly selective neurokinin antagonists. Journal of Medicinal Chemistry. 33(7). 1848–1851. 131 indexed citations

19.

Kilpatrick, Gavin J., et al.. (1990). [3H] GR67330, a very high affinity ligand for 5-HT3 receptors. Naunyn-Schmiedeberg s Archives of Pharmacology. 342(1). 22–30. 25 indexed citations

20.

Hagan, R.M., Brian J. Jones, Christopher Jordan, & M.B. Tyers. (1990). Effect of 5‐HT₃ receptor antagonists on responses to selective activation of mesolimbic dopaminergic pathways in the rat. British Journal of Pharmacology. 99(2). 227–232. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact